NASDAQ:BSGM BioSig Technologies - BSGM Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.00 +0.06 (+6.00%) (As of 02/3/2023 09:03 PM ET) Add Compare Share Share Today's Range$0.94▼$1.0050-Day Range$0.41▼$1.0052-Week Range$0.25▼$1.73Volume197,700 shsAverage Volume251,622 shsMarket Capitalization$54.33 millionP/E RatioN/ADividend YieldN/APrice Target$2.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media BioSig Technologies MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside100.9% Upside$2.00 Price TargetShort InterestHealthy1.75% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.59) to ($0.34) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.08 out of 5 starsMedical Sector466th out of 1,025 stocksElectromedical Equipment Industry12th out of 24 stocks 3.5 Analyst's Opinion Consensus RatingBioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.00, BioSig Technologies has a forecasted upside of 100.9% from its current price of $1.00.Amount of Analyst CoverageBioSig Technologies has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.75% of the outstanding shares of BioSig Technologies have been sold short.Short Interest Ratio / Days to CoverBioSig Technologies has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BioSig Technologies has recently decreased by 36.45%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldBioSig Technologies does not currently pay a dividend.Dividend GrowthBioSig Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BSGM. Previous Next 1.1 News and Social Media Coverage Search Interest7 people have searched for BSGM on MarketBeat in the last 30 days. MarketBeat Follows6 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioSig Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders11.88% of the stock of BioSig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 9.06% of the stock of BioSig Technologies is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for BioSig Technologies are expected to grow in the coming year, from ($0.59) to ($0.34) per share.Price to Book Value per Share RatioBioSig Technologies has a P/B Ratio of 2.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About BioSig Technologies (NASDAQ:BSGM) StockBioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.Read More Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address BSGM Stock News HeadlinesJanuary 19, 2023 | finance.yahoo.comBioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing DevelopmentsDecember 14, 2022 | finance.yahoo.comUpdate: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in SingaporeFebruary 6, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 14, 2022 | finance.yahoo.comIt's Unlikely That BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Will See A Huge Pay Rise This YearDecember 14, 2022 | finance.yahoo.comBioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in SingaporeDecember 6, 2022 | finance.yahoo.comBioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & ElectrophysiologyOctober 24, 2022 | finance.yahoo.comBioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing TechnologyOctober 12, 2022 | finance.yahoo.comBioSig Invited to Attend and Sponsor Venice Arrhythmias 2022February 6, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.October 7, 2022 | finance.yahoo.comBioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer BaseOctober 1, 2022 | seekingalpha.comBSGM BioSig Technologies, Inc.September 22, 2022 | finance.yahoo.comBioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ ModuleSeptember 16, 2022 | finance.yahoo.comTaglich Brothers Initiates Coverage of BioSig Technologies, Inc.September 9, 2022 | finance.yahoo.comThe Zacks Analyst Blog Highlights ShockWave Medical, CheckCap and Biosig TechnologiesSeptember 8, 2022 | finance.yahoo.com3 Medical Instruments Stocks With Potential to OutperformAugust 30, 2022 | finance.yahoo.comBioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial GrowthAugust 24, 2022 | finance.yahoo.comBioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of ExcellenceAugust 17, 2022 | finance.yahoo.comBioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022August 16, 2022 | finance.yahoo.comBioSig Sees Positive Momentum from Sales Pipeline GrowthAugust 6, 2022 | finance.yahoo.comBioSig Technologies, Inc. (BSGM)July 21, 2022 | finance.yahoo.comBioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm InstituteJuly 7, 2022 | finance.yahoo.comBioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical CenterJune 24, 2022 | proactiveinvestors.comBioSig Technologies prices previously announced "best efforts" underwritten public offering to raise around $3.5M grossJune 24, 2022 | seekingalpha.comBioSig Technologies stock slides on $3.5M share offeringJune 23, 2022 | seekingalpha.comBioSig Technologies proposes stock offering to ramp up PURE EP commercializationJune 22, 2022 | seekingalpha.comBioSig enters new evaluation agreement for PURE EP with Cleveland clinicJune 22, 2022 | proactiveinvestors.comBioSig Technologies enters deal for Cleveland Clinic to evaluate its PURE EP signal processing platformSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address BSGM Company Calendar Last Earnings11/14/2022Today2/05/2023Next Earnings (Estimated)2/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BSGM CUSIPN/A CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees49Year FoundedN/APrice Target and Rating Average Stock Price Forecast$2.00 High Stock Price Forecast$2.00 Low Stock Price Forecast$2.00 Forecasted Upside/Downside+100.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-31,920,000.00 Net Margins-18,074.21% Pretax Margin-18,405.66% Return on Equity-380.63% Return on Assets-273.71% Debt Debt-to-Equity RatioN/A Current Ratio1.22 Quick Ratio0.55 Sales & Book Value Annual Sales$159,000.00 Price / Sales341.67 Cash FlowN/A Price / Cash FlowN/A Book Value$0.35 per share Price / Book2.84Miscellaneous Outstanding Shares54,577,000Free Float48,093,000Market Cap$54.33 million OptionableNot Optionable Beta1.50 Key ExecutivesKenneth L. LondonerExecutive Chairman & Chief Executive OfficerJohn SieckhausChief Operating OfficerSteven ChaussyChief Financial OfficerBudimir S. DrakulicChief ScientistZachary KochClinical DirectorKey CompetitorsMovanoNASDAQ:MOVEelectroCoreNASDAQ:ECORSoleno TherapeuticsNASDAQ:SLNOHyperfineNASDAQ:HYPRVivani MedicalNASDAQ:VANIView All CompetitorsInsiders & InstitutionsSimplex Trading LLCSold 2,300 shares on 2/2/2023Ownership: 0.000%Mayo ClinicBought 100,891 shares on 1/26/2023Ownership: 0.185%Vanguard Group Inc.Sold 58,989 shares on 11/15/2022Ownership: 2.206%Citadel Advisors LLCSold 6,600 shares on 11/15/2022Ownership: 0.000%John SieckhausBought 5,000 shares on 9/12/2022Total: $4,550.00 ($0.91/share)View All Insider TransactionsView All Institutional Transactions BSGM Stock - Frequently Asked Questions Should I buy or sell BioSig Technologies stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSGM shares. View BSGM analyst ratings or view top-rated stocks. What is BioSig Technologies' stock price forecast for 2023? 1 Wall Street research analysts have issued twelve-month target prices for BioSig Technologies' stock. Their BSGM share price forecasts range from $2.00 to $2.00. On average, they expect the company's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 100.9% from the stock's current price. View analysts price targets for BSGM or view top-rated stocks among Wall Street analysts. How have BSGM shares performed in 2023? BioSig Technologies' stock was trading at $0.42 at the start of the year. Since then, BSGM stock has increased by 137.0% and is now trading at $0.9954. View the best growth stocks for 2023 here. When is BioSig Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023. View our BSGM earnings forecast. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) released its quarterly earnings results on Monday, November, 14th. The company reported ($0.14) EPS for the quarter, meeting analysts' consensus estimates of ($0.14). The firm earned $0.14 million during the quarter, compared to analysts' expectations of $0.59 million. BioSig Technologies had a negative net margin of 18,074.21% and a negative trailing twelve-month return on equity of 380.63%. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU). What is BioSig Technologies' stock symbol? BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM." Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Mayo Clinic (0.18%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, Jerome B Zeldis, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Martha Pease, Patrick Joseph Gallagher and Steve Chaussy. View institutional ownership trends. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is BioSig Technologies' stock price today? One share of BSGM stock can currently be purchased for approximately $1.00. How much money does BioSig Technologies make? BioSig Technologies (NASDAQ:BSGM) has a market capitalization of $54.33 million and generates $159,000.00 in revenue each year. How can I contact BioSig Technologies? BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The official website for the company is www.biosig.com. The company can be reached via phone at (230) 409-5444 or via email at info@biosigtech.com. This page (NASDAQ:BSGM) was last updated on 2/6/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.